Abstract

The present invention provides for a method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitor effective to decrease extracellular zinc sphingomyelinase activity in the subject and thereby treat the subject. The present invention also provides for a method for determining whether a compound inhibits an activity of an extracellular zinc sphingomyelinase involving ceramide formation which comprises: (a) contacting a sample containing zinc sphingomyelinase under acidic pH conditions known to be associated with the activity of such zinc sphingomyelinase, with: (i) a substrate of the zinc sphingomyelinase enzyme, and (ii) the compound being evaluated; (b) measuring the ceramide in the sample from (a); (c) determining the amount of zinc sphingomyelinase activity in the sample based on the concentration of ceramide measured in step (b); and (d) comparing the amount of sphingomyelinase activity determined in step (c) with the amount of sphingomyelinase activity determined in the absence of the compound, so as to determine whether the compound inhibits the activity of zinc sphingomyelinase.

Other References

• Schissel et al. Circulation, vol. 94, No. 8, Abstract # 0883, 1996.
• Schissel et al. Dissertation Abstracts, vol. 58, No. 9B, 167 pages, DISSABSabstract enclosed, 1997.
• Schissel et al. J. Biol. Chem. vol. 273, No. 5, pp. 2738-2746, Caplus abstract enclosed, 1998.
• Faust, P.L., Wall, D.A., Perara, E., Lingappa, V.R., and Kornfeld, S. (1987) J. Biol. Chem. 269, 22477-22480
• Hannun, Y. A. and R. M. Bell. 1989. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243:500-507
• Kolesnick, R. N. 1991. Sphingomyelin and derivatives as cellular signals. Prog. Lipid Res. 30:1-38
• Levade, T., Salvayre, R., and Blazy-Douste, L. (1986) J. Clin. Chem. Biochem. 24, 205-220
• Okwu, A. K., X. Xu, Y. Shiratori, and I. Tabas. 1994. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content. J. Lipid Res. 35:644-655
• Schissel, S. L., E. H. Schuchman, K. J. Williams, and I. Tabas. 1996. Zn²⁺ -stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem
• Schissel, S. L., Schuchman, E. H., Williams, K. J., and Tabas, I. (1996) J. Biol. Chem. 271, 18431-18436
• Schissel, S. L., J. Tweedie-Hardman, J. H. Rapp, G. Graham, K. J. Williams, and I. Tabas. 1996. Rabbit aorta and human atherosclerotic lesions hydolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98:1455-1464
• Schuchman, E. H., M. Suchi, T. Takahashi, K. Sandhoff, and R. J. Desnick. 1991. Human acid sphingomyelinase. Isolation, nucleotide sequence, and expression of the full-length and alternatively spliced cDNAs. J. Biol. Chem. 266:8531-8539
• Skiba, P. J., X. Zha, S. L. Schissel, F. R. Maxfield, and I. Tabas. 1996. The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent. J. Biol. Chem. 271:13392-13400
• Spence, M. W., D. M. Byers, F. B. St.C.Palmer, and H. W. Cook. 1989. A new Zn²⁺ -stimulated sphingomyelinase in fetal bovine serum. J. Biol. Chem. 264:5358-5363
• Tabas, I., Y. Li, R. W. Brocia, S. W. Wu, T. L. Swenson, and K. J. Williams. 1993. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J. Biol. Chem. 268:20419-20432
• Williams, K. J., G. M. Fless, K. A. Petrie, M. L. Snyder, R. W. Brocia, and T. L. Swenson. 1992. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267:13284-13292
• Williams, K. J. and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:551-561
• Xu, X. and I. Tabas. 1991. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J. Biol. Chem. 266:24849-24858
• Yamamoto, K. (1994) J. Biochem. 116, 229-235